Antiretroviral Therapy Ameliorates Simian Immunodeficiency Virus-Associated Myocardial Inflammation by Dampening Interferon Signaling and Pathogen Response in the Heart

J Infect Dis. 2023 Aug 11;228(3):276-280. doi: 10.1093/infdis/jiad105.

Abstract

People with human immunodeficiency virus have an increased risk of developing cardiovascular disease. RNA-Seq was performed on hearts from simian immunodeficiency virus (SIV)-infected rhesus macaques with or without antiretroviral therapy (ART). SIV infection led to high plasma viral load with very little myocardial viral RNA. SIV infection promoted an inflammatory environment in the heart through interferon and pathogen signaling, in the absence of myocardial viral RNA. While ART dampened interferon and cytokine response in the heart, SIV-infected animals receiving ART had deficits in the expression of genes directly involved in fatty acid metabolism relative to SIV-uninfected animals.

Keywords: RNA-Seq; SIV; interferon; metabolism; nonhuman primates.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • HIV Infections* / complications
  • HIV Infections* / drug therapy
  • Humans
  • Inflammation
  • Interferons
  • Macaca mulatta
  • Myocarditis*
  • RNA, Viral
  • Simian Acquired Immunodeficiency Syndrome* / complications
  • Simian Acquired Immunodeficiency Syndrome* / drug therapy
  • Simian Immunodeficiency Virus* / physiology
  • Viral Load

Substances

  • Interferons
  • RNA, Viral